Did You Know?

Editor’s Picks

Latest News

Lumanity Announces Strategic Partnership with HealthVerity to Provide Streamlined Access to Real-World Data, World-Class Analytics, and Value Demonstration Expertise

Lumanity Announces Strategic Partnership with HealthVerity to Provide Streamlined Access to Real-World Data, World-Class Analytics, and Value Demonstration Expertise Lumanity’s...

Panbela Announces First Patients Enrolled in Europe for ASPIRE Trial Studying Ivospemin (SBP-101) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Ductal Adenocarcinoma

MINNEAPOLIS, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc . (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for...

Junshi Biosciences Announces Submission of a Marketing Authorization Application for Toripalimab to the UK Medicines and Healthcare Products Regulatory Agency

-- 2nd MAA submission in Europe reflects toripalimab’s steady yet speedy progress towards global commercializationSHANGHAI, China, Nov. 24, 2022 (GLOBE...

Patients will benefit if Europe modernizes its policy framework to reflect the distinct promise of cell and gene therapy, the Alliance for Regenerative Medicine will highlight in 29 November EU Parliament event

error: Content is protected !!